Topical treatment of periocular basal cell epithelioma with solcoderm

Esther Azizi*, David Semach, Miriam Schewach-Millet, Issac Avni, Oded Ben-Haim, Giora Treister, Michael Blumenthal, Michael Belkin

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


25 patients with 29 histologically confirmed periocular basal cell epitheliomas were treated by topical application of Solcoderm, a solution of organic and inorganic acids and ions. The cure rate of the 29 lesions, which were followed for a mean period of 32 months, was 80%. The overall cure rate following second Solcoderm treatment of the 6 recurrent lesions was 96.7%. The cosmetic and functional results were excellent and there were no serious complications and side effects.

Original languageEnglish
Pages (from-to)116-120
Number of pages5
Issue number3
StatePublished - 1984


  • Basal cell epithelioma
  • Eyelid tumors
  • Solcoderm
  • Topical treatment

Cite this